サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1587499

組織工学の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年

Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Orthopedics, Musculoskeletal, & Spine, Urology), By Region And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
組織工学の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月08日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

組織工学市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の組織工学市場規模は2030年までに431億3,000万米ドルに達し、2025年から2030年にかけて推定CAGR 14.3％で成長すると推定されています。

心血管疾患、糖尿病、整形外科疾患などの慢性疾患の増加により、損傷した組織を修復または置換する組織工学ソリューションの需要が高まっています。生体材料、3Dバイオプリンティング、幹細胞研究、遺伝子編集技術の進歩が組織工学の分野を推進し、複雑で機能的な組織の開発を可能にしています。

同種組織移植法は、自家移植の使用や利用しやすさに関連する課題や限界に効果的に対処しています。加えて、同種インプラントを生体インプラントに変換することを目的とした、インプラントの固定や滅菌などの特殊な処置の進歩が、この市場の収益を押し上げると予想されています。

組織再生技術は、その効果的な製品と低い拒絶反応率により人気を集めており、再生治療の増加につながっています。前臨床研究では現在、心臓血管外科手術や治療における組織工学的人工血管の使用に焦点が当てられています。さらに、組織工学的膀胱は現在、患者の体外への移植に成功しています。こうした進歩にもかかわらず、市場の成長を妨げているのは、製品開発コストの高さや、幹細胞研究や組織工学製品を取り巻く倫理的懸念といった課題です。

組織工学市場のレポートハイライト

  • 整形外科、筋骨格系、脊椎部門は、筋骨格系障害の有病率の増加により、2024年には59.21%の市場シェアで最大の収益を占めました。
  • 北米が市場を独占し、2024年には51.30%の最大売上シェアを占めました。これは、幹細胞治療に対する意識の高まり、高齢者人口の増加、慢性疾患の罹患率の上昇に起因します。
  • アジア太平洋地域の組織工学市場は、市場推計・予測期間中に19.04%のCAGRを記録すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 組織工学市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 組織工学市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 用途ビジネス分析

  • セグメントダッシュボード
  • 世界の組織工学市場の用途変動分析
  • 世界の組織工学市場規模と動向分析、用途別、2018～2030年
  • 臍帯血と細胞バンキング
  • がん
  • 消化器科/婦人科
  • 歯科
  • 皮膚と外皮
  • 泌尿器科
  • 整形外科、筋骨格、脊椎
  • 神経学
  • 心臓血管学
  • その他

第5章 地域ビジネス分析

  • 地域ダッシュボード
  • 組織工学市場：地域別シェア、2024年および2030年
  • 北米
    • 北米組織工学市場、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の組織工学市場、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • アジア太平洋地域の組織工学市場、2018年-2030年
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの組織工学市場、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ組織工学市場、2018-2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 2024 年の企業ポジション分析
  • 企業プロファイル/リスト
    • Zimmer Biomet Holdings, Inc.
    • AbbVie（Allergan）
    • Becton, Dickinson and Company
    • B. Braun
    • Integra LifeSciences Corporation
    • Organogenesis Holdings Inc.
    • Medtronic
    • ACell, Inc.
    • Athersys, Inc.
    • Tissue Regenix Group plc
    • Stryker Corporation
    • RTI Surgical, Inc.
    • ReproCell, Inc.
    • Baxter International, Inc.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global tissue engineering market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 12 Germany tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 14 France tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 17 Sweden tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 18 Norway tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 19 Denmark tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 21 APAC tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 22 China tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 23 Japan tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 24 India tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 25 Thailand tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 30 Argentina tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 31 Middle East and Africa tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East and Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 33 South Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 35 UAE tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 36 Kuwait tissue engineering market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Tissue engineering: market outlook
  • Fig. 9 Tissue engineering competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Tissue engineering market driver impact
  • Fig. 15 Tissue engineering market restraint impact
  • Fig. 16 Tissue engineering market strategic initiatives analysis
  • Fig. 17 Global tissue engineering market: application movement analysis
  • Fig. 18 Global tissue engineering market: application outlook and key takeaways
  • Fig. 19 Global cord blood & Cell Banking market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 20 Global cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global GI, Gynecology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Global dental market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Global skin & Integumentary market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global urology market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 25 Global orthopedics, Musculoskeletal, & Spine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global cardiology & Vascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global tissue engineering market: regional movement analysis
  • Fig. 30 Global tissue engineering market: regional outlook and key takeaways
  • Fig. 31 Global market share and leading players
  • Fig. 32 North America market, SWOT analysis
  • Fig. 33 Europe market, SWOT analysis
  • Fig. 34 Asia Pacific market, SWOT analysis
  • Fig. 35 Latin America market, SWOT analysis
  • Fig. 36 Middle East & Africa market, SWOT analysis
  • Fig. 37 North America
  • Fig. 38 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Participant categorization- Tissue engineering market
  • Fig. 67 Market position of key market players- Tissue engineering market
目次
Product Code: 978-1-68038-768-1

Tissue Engineering Market Growth & Trends:

The global tissue engineering market size is estimated to reach USD 43.13 billion by 2030, growing at an estimated CAGR of 14.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders, has driven the demand for tissue engineering solutions that can repair or replace damaged tissues. Advances in biomaterials, 3D bioprinting, stem cell research, and gene editing techniques have propelled the field of tissue engineering, enabling the development of complex and functional tissues.

The allogeneic tissue transplant method effectively addresses the challenges and limitations associated with the use and accessibility of autologous transplants. In addition, the advancement of specialized procedures, such as implant fixing and sterilization, aimed at converting allogeneic implants into biostatic implants, is anticipated to boost revenue generation in this market.

Tissue regeneration technology is gaining popularity due to its effective products and low rejection rates, leading to an increase in regeneration treatments. Pre-clinical research is currently focused on the use of tissue-engineered vascular grafts in cardiovascular surgery and treatment. Moreover, tissue-engineered bladders can now be successfully implanted outside of the patient's body. Despite these advancements, the market's growth is hindered by challenges such as the high cost of product development and ethical concerns surrounding stem cell research and tissue-engineered products.

Tissue Engineering Market Report Highlights:

  • The orthopedics, musculoskeletal, & spine segment held the largest revenue of 59.21% market share in 2024, owing to the increasing prevalence of musculoskeletal disorders.
  • North America dominated the market and accounted for the largest revenue share of 51.30% in 2024, owing to rising awareness of stem cell therapy, the growing geriatric population, and the rising incidence of chronic diseases.
  • The market for tissue engineering in Asia Pacific is estimated to witness the fastest CAGR of 19.04% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Tissue Engineering Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in stem cell technology & tissue engineering
      • 3.2.1.2. Rise in number of clinical studies for Tissue Engineering and tissue engineering
      • 3.2.1.3. Increasing tissue engineering research funding
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product development
      • 3.2.2.2. Ethical concerns related to stem cell research & tissue engineered product
      • 3.2.2.3. Clinical issues pertaining to development & implementation of stem cell therapies
  • 3.3. Tissue Engineering Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Tissue Engineering Market Application Movement Analysis
  • 4.3. Global Tissue Engineering Market Size & Trend Analysis, by Specimen, 2018 to 2030 (USD Million)
  • 4.4. Cord blood & Cell banking
    • 4.4.1. Cord blood & Cell banking market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Cancer
    • 4.5.1. Cancer market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. GI/Gynecology
    • 4.6.1. GI/Gynecology therapy market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Dental
    • 4.7.1. Dental market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Skin & Integumentary
    • 4.8.1. Skin & Integumentary market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Urology
    • 4.9.1. Urology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Orthopedics, Musculoskeletal, & Spine
    • 4.10.1. Orthopedics, Musculoskeletal, & Spine market estimates and forecast 2018 - 2030 (USD Million)
  • 4.11. Neurology
    • 4.11.1. Neurology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.12. Cardiology & Vascular
    • 4.12.1. Cardiology & Vascular market estimates and forecast 2018 - 2030 (USD Million)
  • 4.13. Others
    • 4.13.1. Others market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Dashboard
  • 5.2. Tissue Engineering Market: Share By Region, 2024 & 2030
  • 5.3. North America
    • 5.3.1. North America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Mexico Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Sweden Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Norway Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Denmark Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. China Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Japan Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Australia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Thailand Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. South Korea Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Brazil Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Argentina Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. South Africa Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Saudi Arabia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. UAE Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Kuwait Tissue Engineering Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Position Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. Zimmer Biomet Holdings, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. AbbVie (Allergan)
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Becton, Dickinson and Company
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. B. Braun
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Integra LifeSciences Corporation
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Organogenesis Holdings Inc.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Medtronic
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. ACell, Inc.
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Athersys, Inc.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Tissue Regenix Group plc
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Stryker Corporation
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. RTI Surgical, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. ReproCell, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Baxter International, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives